These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11094416)

  • 1. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.
    Goldring SR; Gravallese EM
    Arthritis Res; 2000; 2(1):33-7. PubMed ID: 11094416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histomorphometry of periarticular bone in rheumatoid arthritis.
    Kröger H; Arnala I; Rehnberg V; Hämäläinen M; Alhava E
    Ann Chir Gynaecol; 1994; 83(1):56-62. PubMed ID: 8053640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inflammation and bone metabolism in rheumatoid arthritis. Pathogenetic viewpoints and therapeutic possibilities].
    Oelzner P; Hein G
    Med Klin (Munich); 1997 Oct; 92(10):607-14. PubMed ID: 9446010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis in rheumatoid arthritis].
    Suzuki Y; Uehara R; Ide M; Ichikawa Y
    Nihon Rinsho; 1998 Jun; 56(6):1598-603. PubMed ID: 9648488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone structure in rheumatoid arthritis].
    Ono K; Ohashi S; Tanaka S; Matsumoto T
    Clin Calcium; 2013 Jul; 23(7):983-91. PubMed ID: 23811586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone changes in early rheumatoid arthritis.
    Green MJ; Deodhar AA
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):105-23. PubMed ID: 11358418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measure of bone loss in rheumatoid arthritis].
    Náfrádi L; Toldy E; Varga L
    Orv Hetil; 1999 Feb; 140(6):281-4. PubMed ID: 10071506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone and joint destruction in rheumatoid arthritis: what is really happening?
    Goldring SR
    J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone tissue in rheumatoid arthritis (2). Pathophysiologic data, pathologic findings, and therapeutic implications.
    Cortet B; Flipo RM; Duquesnoy B; Delcambre B
    Rev Rhum Engl Ed; 1995 Mar; 62(3):205-11. PubMed ID: 7788338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Generalized osteoporosis in chronic polyarthritis--pathomechanisms and treatment approaches].
    Ringe JD
    Z Rheumatol; 1996; 55(3):149-57. PubMed ID: 8768144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
    Güler-Yüksel M; Bijsterbosch J; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Hulsmans HM; de Beus WM; Han KH; Breedveld FC; Dijkmans BA; Allaart CF; Lems WF
    Ann Rheum Dis; 2008 Jun; 67(6):823-8. PubMed ID: 17644545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specialties in therapy of osteoporosis in inflammatory joint disease].
    Franck H; Braun J; Buttgereit F; Dreher R; Hein G; Kekow J
    Z Rheumatol; 2004 Jun; 63(3):223-9. PubMed ID: 15224226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
    Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
    Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
    Stolina M; Adamu S; Ominsky M; Dwyer D; Asuncion F; Geng Z; Middleton S; Brown H; Pretorius J; Schett G; Bolon B; Feige U; Zack D; Kostenuik PJ
    J Bone Miner Res; 2005 Oct; 20(10):1756-65. PubMed ID: 16160733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteoporosis in rheumatoid arthritis].
    Teshima R; Yamamoto K; Hagino H; Kagawa T
    Nihon Rinsho; 1992 Mar; 50(3):592-6. PubMed ID: 1588754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and prediction of joint destruction found in patients with rheumatoid arthritis using by biochemical markers].
    Eguchi K
    Nihon Rinsho; 2005 Sep; 63(9):1586-93. PubMed ID: 16164216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatic diseases: the effects of inflammation on bone.
    Walsh NC; Crotti TN; Goldring SR; Gravallese EM
    Immunol Rev; 2005 Dec; 208():228-51. PubMed ID: 16313352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cell-substrate interaction in regulating osteoclast activation: potential implications in targeting bone loss in rheumatoid arthritis.
    McHugh KP; Shen Z; Crotti TN; Flannery MR; O'Sullivan RP; Purdue PE; Goldring SR
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i83-85. PubMed ID: 19995752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review.
    Deodhar AA; Woolf AD
    Br J Rheumatol; 1996 Apr; 35(4):309-22. PubMed ID: 8624634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.